LAVAL, Quebec, Feb. 6, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.
Valeant Pharmaceuticals International Inc. published this content on 06 February 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 06 February 2018 15:30:06 UTC.